Drug Industry’s Chief Lobbying Group’s Revenue Surpassed $609 Million in 2021

  • 📰 truthout
  • ⏱ Reading Time:
  • 31 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 16%
  • Publisher: 68%

Malaysia News News

Malaysia Malaysia Latest News,Malaysia Malaysia Headlines

In 2021, the drug industry’s chief lobbying group surpassed $609 million in revenues and spent more than $205 million on lobbying. Via Sludge

PhRMA represents 33 American and multinational drug companies, including the largest ones like Pfizer, Johnson & Johnson, AbbVie, and Merck. Its chief executive office since 2015, Stephen Ubl, was paid more than $6.1 million in 2021, according to the tax filing.

One of PhRMA’s chief aims in 2021 was to kill a proposal that congressional Democrats had been pushing in recent years to allow Medicare to negotiate with drug companies for lower prices and require drug companies to make the lower negotiated prices available to all buyers, including private insurance companies. That proposal sat in Congress as H.R.3, which is by far thein PhRMA’s 2021 lobbying disclosures.

Another large contribution made by PhRMA in 2021 was a $1.7 million donation to Center Forward, which is a nonprofit tied to the conservative Blue Dog Caucus of Democrats that has

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

PortCityPisces Sludge

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 69. in MY

Malaysia Malaysia Latest News, Malaysia Malaysia Headlines